Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8634)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee MY, Jung KS, Kim HS, Lee JY, Lim SH, Kim M, Jung HA, Kim SM, Sun JM, Ahn MJ, Lee J, Park SH, Yi SY, Hwang IG, Lee SC, Ahn HK, Lim DH, Lee SI, Park KW. Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(14): 4268-4274 [PMID: 25892878 DOI: 10.3748/wjg.v21.i14.4268] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4268.htm |
| Number | Citing Articles |
| 1 |
Luis Paz-Ares, Martin Forster, Valentina Boni, Sergio Szyldergemajn, Jesús Corral, Samantha Turnbull, Antonio Cubillo, Carlos Fernandez Teruel, Iker López Calderero, Mariano Siguero, Patrick Bohan, Emiliano Calvo. Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors. Investigational New Drugs 2017; 35(2): 198 doi: 10.1007/s10637-016-0410-3
|
| 2 |
Kei Muro, Takashi Kojima, Toshikazu Moriwaki, Ken Kato, Fumio Nagashima, Hisato Kawakami, Ryu Ishihara, Takashi Ogata, Taroh Satoh, Keiichi Iwakami, Shirong Han, Naoyoshi Yatsuzuka, Tomoko Takami, Pooja Bhagia, Toshihiko Doi. Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181. Esophagus 2022; 19(1): 137 doi: 10.1007/s10388-021-00877-3
|
| 3 |
Yongjing Liu, Zhaohui Xiong, Andrea Beasley, Thomas D'Amico, Xiaoxin Luke Chen. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. Annals of the New York Academy of Sciences 2016; 1381(1): 66 doi: 10.1111/nyas.13144
|
| 4 |
Hiroki Imamura, Hajime Hirose, Shunji Endo, Yasuji Hashimoto, Masashi Takeda, Shinya Kidogami, Yukako Mokutani, Tomoya Kishimoto, Shinichi Yoshioka, Shigeyuki Tamura, Yo Sasaki. Simultaneous triple cancer of the esophagus, pancreas and rectum treated with multimodal strategies: a case report. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-01035-0
|
| 5 |
Zinab Mohammadi, Jahanbakhsh Asadi, Seyyed Mehdi Jafari. Synergistic effects of BAY606583 on docetaxel in esophageal cancer through modulation of ERK1/2. Cell Biochemistry and Function 2022; 40(6): 569 doi: 10.1002/cbf.3726
|
| 6 |
Mourad Sanhaji, Julia Göring, Pierre Couleaud, Antonio Aires, Aitziber L. Cortajarena, José Courty, Adriele Prina-Mello, Marcus Stapf, Robert Ludwig, Yuri Volkov, Alfonso Latorre, Álvaro Somoza, Rodolfo Miranda, Ingrid Hilger. The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt. Nanomedicine: Nanotechnology, Biology and Medicine 2019; 20: 101983 doi: 10.1016/j.nano.2018.12.019
|
| 7 |
Rui-Xue Huo, Ying-Ying Jin, Yong-Xue Zhuo, Xiao-Tong Ji, Yu Cui, Xiao-Jing Wu, Yi-Jia Wang, Long Zhang, Wen-Hua Zhang, Yu-Mei Cai, Cheng-Cheng Zheng, Rui-Xue Cui, Qian-Ye Wang, Zhen Sun, Feng-Wei Wang. Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma. World Journal of Clinical Cases 2022; 10(11): 3414-3425 doi: 10.12998/wjcc.v10.i11.3414
|
| 8 |
Boshra haghi, Marie Saghaeian jazi, Mahdi zarie, Ayyoob Khosravi, mahboubeh tajaldini, Jahanbakhsh Asadi. Docetaxel Toxicity Optimization in Esophageal Squamous Cell Carcinoma Cell Line YM-1: A Study of Cell Cycle and Doubling Time Effect. Medical Laboratory Journal 2021; 15(2): 23 doi: 10.52547/mlj.15.2.23
|